IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1249 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (1,361 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures

 Article Access Statistics
    Viewed1004    
    Printed15    
    Emailed0    
    PDF Downloaded23    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR - CASE LETTER
Year : 2017  |  Volume : 83  |  Issue : 1  |  Page : 91-93

Mucocutaneous leishmaniasis with marked facial disfigurement


1 Department of Dermatology, Tayfur Ata Sokmen Medical School, Mustafa Kemal University, Antakya, Hatay, Turkey
2 Department of Otolaryngology, Medical Faculty of Mustafa Kemal University, Antakya, Hatay, Turkey
3 Department of Parasitology, School of Medicine, Mustafa Kemal University, Antakya, Hatay, Turkey
4 Department of Pathology, School of Medicine, Mustafa Kemal University, Antakya, Hatay, Turkey

Date of Web Publication2-Dec-2016

Correspondence Address:
Ozlem Ekiz
Department of Dermatology, Tayfur Ata Sokmen Medical School, Mustafa Kemal University, Antakya, Hatay 31000
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.190848

Rights and Permissions



How to cite this article:
Ekiz O, Kahraman &&, Şen BB, Serarslan G, Rifaioğlu EN, Culha G, Özgür T. Mucocutaneous leishmaniasis with marked facial disfigurement. Indian J Dermatol Venereol Leprol 2017;83:91-3

How to cite this URL:
Ekiz O, Kahraman &&, Şen BB, Serarslan G, Rifaioğlu EN, Culha G, Özgür T. Mucocutaneous leishmaniasis with marked facial disfigurement. Indian J Dermatol Venereol Leprol [serial online] 2017 [cited 2017 Sep 19];83:91-3. Available from: http://www.ijdvl.com/text.asp?2017/83/1/91/190848


Sir,

A 52-year-old Syrian presented to the dermatology department at Hatay Mustafa Kemal University with complaints of facial lesions and purulent rhinitis for 3 months. He also had vitiligo for 20 years. The patient had no history of smoking, alcohol consumption or systemic disease. Dermatologic examination revealed crusted and infiltrated granulomatous plaques on the anterior upper surface and side of the nose, cheeks and lower and upper lips with purulent discharge [Figure 1]. The lesions had affected the anterior nasal septum and columella. Nasal examination showed mucopus in the nasal cavity, loss of tissue on the columella and cartilage necrosis on the anterior nasal septum and consequently, loss of tip support. In addition, depigmented macules of vitiligo were noted on the face and extremities. General physical examination was normal. Laboratory tests revealed that the white blood cell count was 20.86 × 10[3]/µL (4–10 × 10[3]/µL),
Figure 1: Massively crusted, granulomatous plaques on the central and lower face

Click here to view


sedimentation rate was 100 mm/h (0–12 mm/h) and C-reactive protein levels were 86.6 mg/dl (0–5 mg/dl). Other laboratory tests were within normal limits. HIV and hepatitis C tests were negative. Culture from the purulent discharge grew Pseudomonas aeruginosa. The patient was treated with levofloxacin, 750 mg by intravenous infusion for 10 days. Following treatment, suppuration decreased and granulomatous lesions became more visible. Histopathologic examination revealed acanthosis with pustule formation on the surface of follicular epithelium and a dense, diffuse inflammatory infiltrate of lymphocytes, many plasma cells and epithelioid cells in the papillary and reticular dermis [Figure 2]a and [Figure 2]b. These findings were suggestive of mucocutaneous leishmaniasis but no parasite was seen. Leishmania amastigotes were found in the tissue smear prepared from the edge of the lesion [Figure 3]. On the basis of history, clinical and histopathological findings and skin smear results, mucocutaneous leishmaniasis was diagnosed. The patient was treated with systemic meglumine antimoniate, 20 mg/kg/day intramuscularly, in 2 divided doses for 30 days. The lesions improved dramatically 1 month after the treatment [Figure 4].
Figure 2: (a and b) Acanthosis of the epidermis (e), pustule formation on the surface of the follicle, lymphocytes (l), plasma cells (pc) mixed with epithelioid histiocytes (eh) in the papillary (pd) and reticular dermis (rt) (H and E, ×40, ×100)

Click here to view
Figure 3: Leishmania amastigotes in the tissue smear (Giemsa stain, × 100)

Click here to view
Figure 4: Significant improvement 1 month after the treatment

Click here to view


Mucocutaneous leishmaniasis is a serious and potentially life-threatening form of the disease. It is often perceived as a New World disease almost only found in South America but rarely seen in the Old World. Mucosal manifestations can be seen in about 5–20% of cutaneous leishmaniasis. The lag period between developing cutaneous lesions and the later onset of mucosal involvement ranges from months to years. The nasal mucosa is the most commonly affected area and involvement of other mucosal sites is rare.[1] In patients with nasal mucosal involvement, the disease can begin with non-specific symptoms such as persistent nasal stuffiness, discharge, discomfort or epistaxis.[2] Our patient also presented with purulent nasal discharge.

Secondary infection is reported in 54.2% of cases and is usually caused by Staphylococcus aureus.[3] In our case, Pseudomonas aeruginosa was the cause and the patient responded well to treatment with levofloxacin.

Atypical aspects such as extensive and destructive lesions, have often been found in cases of leishmaniasis associated with HIV infection.[4] In our case, although HIV tests were negative, a massive and disfiguring central face involvement occurred in a short time.

The clinching evidence for a diagnosis of mucocutaneous leishmaniasis is the demonstration of Leishmania parasites. On biopsy, amastigotes can be seen in only 25% of the skin lesions.[5] In our case, the histopathological findings were suggestive of mucocutaneous leishmaniasis but amastigotes could not be identified. However, amastigotes were detected by direct microscopic examination.

In mucocutaneous leishmaniasis, long-term systemic treatment with pentavalent antimonials or amphotericin B is required.[5] In view of the extent and severity of the disease, our patient was treated with intramuscular meglumine antimoniate, 20 mg/kg/day for 30 days. Because of the fairly early diagnosis, appropriate treatment and the absence of any underlying primary immunodeficiency, our patient had a good prognosis. In addition, the response to treatment was dramatic.

Early diagnosis and appropriate treatment of mucocutaneous leishmaniasis is essential as there is a risk of extension of the disease and destruction of facial structures such as the nose, palate and buccal mucosa with potentially fatal pharyngeal and laryngeal involvement.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has given his consent for his images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Osorio LE, Castillo CM, Ochoa MT. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: Clinical characteristics. Am J Trop Med Hyg 1998;59:49-52.  Back to cited text no. 1
    
2.
Weller PF, Durand ML, Pilch BZ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-2005. A 35-year-old man with nasal congestion, swelling, and pain. N Engl J Med 2005;352:609-15.  Back to cited text no. 2
    
3.
Vera LA, Macedo JL, Ciuffo IA, Santos CG, Santos JB. Antimicrobial susceptibility of aerobic bacteria isolated from leishmaniotic ulcers in Corte de Pedra, BA. Rev Soc Bras Med Trop 2006;39:47-50.  Back to cited text no. 3
    
4.
da Silva GA, Sugui D, Nunes RF, de Azevedo K, de Azevedo M, Marques A, et al. Mucocutaneous leishmaniasis/HIV coinfection presented as a diffuse desquamative rash. Case Rep Infect Dis 2014;2014:293761.  Back to cited text no. 4
    
5.
Costa JM, Saldanha AC, Nasciento D, Sampaio G, Carneiro F, Lisboa E, et al. Clınıcal modalıtıes, dıagnosıs and therapeutıc approach of the tegumentary leıshmanıasıs ın Brazıl. Bras Gaz Med Bahia 2009;79 Suppl 3:70-83.  Back to cited text no. 5
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]



 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow